top read note buysid
report highlight
top note septemb includ list key catalyst year-end
thought kra data sector sentiment/posit ye deep dive
grow pipelin industri podcast multimedia report
biotech innov rest top report insid w/ full tabl addit highlight
add report team contain uniqu insights/differenti view
revisit
new kra data still strong moder high expect buy sep
industri posit year end thought sep
deep dive data come w/ upsid potenti sep
industri podcast bench bedsid rapidli chang sep
fda comment new highlight opportun sep
industri west west meet new myeloma nash aug
kra data come weekend esmo sep
management say increas confid earli reimburs sep
updat data competitor eli lilli nc non-
small cell lung cancer wclc show overal respons rate orr
continu slightli numer better bpmc show orr
howev long-term clinic util two compet drug remain seen per
prior expert potenti differenti would come resist profil earli
tell intracrani activ like similar first-to-market us ahead
month reiter nda file
plan file nda
 imw key discuss focus bcma cart fit rel
bcma-target therapi context current durabl discuss
time given issu overhang share given
emerg competit landscap discuss center use car-t and/
bispecifics/adc emerg evid suggest sequenti use differ
bcma-target modal besid cart anoth potenti
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
competitor bcma-target bite shown promis
efficaci signal requir continu infus pursuit infrequ deliveri
bite develop first data expect
analysi preclin studi suggest similar drug potenc t-cell activ
mediat vs may depend baselin bcma level
insid addit comment yang amin raycroft howerton
pleas see import disclosur inform page report
ncna host investor meet hugh griffith ceo munoz cfo
ncna new york event next month start lead drug acelarin
biliari cancer octob earli efficaci data product colorect
cancer ncna continu see current cash
suffici includ initi key registr studi
acelarin biliari cancer acknowledg
addit capit need see ncna posit favor upsid potenti
anticip increment data flow given modest expect
current ev
 recent publish road map ph studi mdd pt
anxieti determin point differ pbo madr scale would
meaning provid result stat sig current soc agent show madr chang
point ham-a scale think -like effect point could
meaning
highlight upgrad see wider window better
expect first data updat potenti show best-in-class monotherapi
data would buy current level also highlight downgrad
anticip major catalyst sever quarter recommend investor
hold stock note new cohort high-dos data
support benefit moa recent remov financ overhang note
enter seemingli favor royalti come w/ initi launch number
ph iii boston horizon zlab report earn recent note
co report strong hk launch figur includ estimate impress parp market share
help derisk set stage china launch also note vrtx-
semma acquisit potenti readthrough crsp final highlight note
arwr new data highlight impress knockdown serum
biomark show consist w/ arwr program aat hbv respect
target knockdown safeti impli dose
chri howerton key report
initi microbiom catalyst
initi coverag buy pt w/ view gx korlym challeng
winnabl relacoril could expand market share buy pt w/
high po clinic regulatori commerci recorlev also includ cush
syndrom primer cs survey initi report identifi
microbiom base therapeut mbt clinic studi expect readout within
rcdi studi result could biggest catalyst see sig readthrough
due lack sophist continu like mechanist driven platform
compani preview upcom muc
interim data present esmo expect share react veli data look
consist w/ note look muc addit view
pleas see import disclosur inform page report
nt comp keep watch profil includ lung tox
assess lt competit urgn investor event view
durabl data commerci prep support launch initi cr line
howev note durabl pivot design would key obviat nt
uncertainty/concern
top note last week
pleas see import disclosur inform page report
tickertitled stock-mov catalyst ye upside/downsid expectationsseptemb kra data still strong moder high expect buyseptemb year end thought amrnseptemb dive data come w/ upsid potenti new call bench bedsid rapidli chang futur biotechseptemb fda comment new highlight opportun question buyseptemb west meet new myeloma nash drugsaugust jefferi therapy/edit summit come octob kra data come weekend esmoseptemb wclc kra data widen window -- upgrad buyseptemb say increas confid earli reimburs access alreadi septemb esc guidelin chang alreadi add vascepa recommend useseptemb keep get interest w/ new cell therapi acquisit buyseptemb cs rx mayb space isnt hairi initi buyseptemb new pdufa place script keep grow strongseptemb microbiome-bas catalyst monthsseptemb burn rate last year grow need soon septemb call takeaway corrector could expand under-diagnos marketseptemb ipr institut creat overhangseptemb deal interest may reduc financ risk overhang axgtseptemb asn slot continu add confid updat debatesseptemb meet takeaway histor adcom cancel suggest septemb data look solid de-risk hbv updat tooseptemb threat microbiom catalyst pot opportunitiesseptemb posit develop cf septemb call call discuss defici new approachesseptemb look muc pivot data esmo comp wclcseptemb multipl sclerosi data earli tab-cel car-t quiet downgrad holdseptemb orr nsclc comp ild caus concernsseptemb data add profil confirm fda mid-cycl review pass panelaugust data support benefit moa optim still neededseptemb look differenti highlight far lead time ocaseptemb sarcoma look approv base esmo pot approv jan on-track launch clear util approv pathseptemb fda adcom plan favor risk/reward decemb approvalseptemb w/ hcr ms favor remov financ overhangseptemb /data expect stock move investor eventseptemb script imw call w/ co -- compani updatesseptemb conf call thought time wclc new trial septemb mito zlab ct gov -- updatesseptemb fairli price await better entri point assum holdseptemb strong hk launch help de-risk predict china oppti much ahead growth hormon ole data -- red flag set stage ph iii readoutseptemb investor feedback new epilepsi dataseptemb event alna highlight relox potenti clinic commerci impactseptemb dme data on-demand complet expect phase ii seizur data impress takeaway thought hold headlin great optic ms incrementalseptemb data kaufmann model support higher dose bridg studi still septemb deal accret buy dip today reiter buyaugust equiti research
javatar bluematrix com/sellside/disclosur action call
inform compani recommend
report pleas visit websit http //
michael yee certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
biren amin certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
eun yang ph certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
mauri raycroft ph certifi view express research report accur reflect person view
subject secur subject compani also certifi part compens directli indirectli
relat specif recommend view express research report
chri howerton phd certifi view express research report accur reflect person view
subject secur subject compani also certifi part compens directli indirectli
relat specif recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom seek
updat research appropri variou regul may prevent us asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgement
articl articl
act financi advisor review strateg option
jefferi llc act financi advisor nightstar therapeut plc announc acquisit biogen inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr axov gene therapi ltd
jefferi group llc make market secur adr biogen inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr blueprint medicin corpor
jefferi group llc make market secur adr
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr esperion inc
jefferi group llc make market secur adr fibrogen inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr intra-cellular therapi inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr
jefferi group llc make market secur adr nucana plc
jefferi group llc make market secur adr inc
pleas see import disclosur inform page report
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr synlog inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr vertex pharmaceut incorpor
jefferi group llc make market secur adr zai lab limit
jefferi group llc make market secur adr inc
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
abeona inc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili
within past twelv month inc client jefferi llc invest bank servic
provid
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic axov gene therapi ltd
within past twelv month axov gene therapi ltd client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
axov gene therapi ltd one affili within past twelv month
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
crispr within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
one affili
within past twelv month client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
one affili
within past twelv month client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
one affili within past twelv month
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
karyopharm inc within next three month
pleas see import disclosur inform page report
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili
within past twelv month inc client jefferi llc invest bank servic
provid
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
nucana plc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic nucana plc
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
nucana plc one affili
within past twelv month nucana plc client jefferi llc invest bank servic
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic
within past twelv month ltd client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
ltd one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic zai lab limit
within past twelv month zai lab limit client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
zai lab limit one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
